ELVN · Enliven Therapeutics, Inc. · Documents
$41.52
-0.41 (-0.98%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$3.04B
Shares
73.27M
Volume · Oct 23
2.3M
Avg daily vol (3M)
1.27M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-K | — | 2024-03-14 | 2023-12-31 | |
| 8-K | — | 2023-11-09 | — | |
| 10-Q | — | 2023-11-09 | 2023-09-30 | |
| 8-K | — | 2023-08-10 | — | |
| 10-Q | — | 2023-08-10 | 2023-06-30 | |
| 8-K | — | 2023-06-26 | 2023-06-23 | |
| S-3 | — | 2023-06-23 | — | |
| 8-K | — | 2023-06-23 | — | |
| 8-K | — | 2023-05-11 | — | |
| 10-Q | — | 2023-05-11 | 2023-03-31 | |
| DEF 14A | — | 2023-04-28 | 2023-06-23 | |
| ARS | — | 2023-04-28 | 2022-12-31 | |
| DEFA14A | — | 2023-04-28 | — | |
| 8-K/A | — | 2023-03-21 | 2023-02-23 | |
| 8-K | — | 2023-03-01 | 2023-02-23 | |
| 8-K | — | 2023-02-22 | — | |
| 8-K | — | 2023-02-13 | — | |
| 10-K | — | 2023-02-10 | 2022-12-31 | |
| S-4/A | — | 2023-01-09 | — | |
| S-4/A | — | 2022-12-19 | — | |
| 8-K | — | 2022-12-05 | 2022-11-28 | |
| 8-K/A | — | 2022-11-16 | 2022-11-10 | |
| S-4 | — | 2022-11-10 | — | |
| 8-K | — | 2022-11-10 | 2022-11-09 | |
| 10-Q | — | 2022-10-25 | 2022-09-30 | |
| DEFA14A | — | 2022-10-19 | — | |
| 8-K | — | 2022-10-14 | 2022-10-13 | |
| 8-K | — | 2022-10-13 | — | |
| DEFM14A | — | 2022-10-07 | — | |
| PREM14A | — | 2022-09-23 | — | |
| 8-K | — | 2022-09-07 | 2022-09-06 | |
| DEFA14A | — | 2022-09-07 | — | |
| 10-Q | — | 2022-08-03 | 2022-06-30 | |
| 8-K | — | 2022-07-29 | 2022-07-25 | |
| 8-K | — | 2022-06-03 | 2022-06-02 | |
| 10-Q | — | 2022-05-06 | 2022-03-31 | |
| DEF 14A | — | 2022-04-22 | 2022-06-02 | |
| DEFA14A | — | 2022-04-22 | — | |
| 8-K | — | 2022-04-14 | 2022-04-05 | |
| 10-K | — | 2022-03-15 | 2021-12-31 | |
| 8-K | — | 2022-03-15 | — | |
| 8-K | — | 2021-11-09 | — | |
| 10-Q | — | 2021-11-09 | 2021-09-30 | |
| 8-K | — | 2021-10-25 | 2021-10-21 | |
| 8-K | — | 2021-08-06 | — | |
| 10-Q | — | 2021-08-06 | 2021-06-30 | |
| 8-K | — | 2021-07-14 | 2021-07-13 | |
| 8-K | — | 2021-07-13 | — | |
| 8-K | — | 2021-06-30 | 2021-06-29 | |
| 8-K | — | 2021-06-11 | 2021-06-08 |
Showing 51–100 of 119 filings
Key facts
CIK
1672619
CUSIP
29337E102
13F (30d)
14 filings
14 filers
Visit website
Investor relations